Identification of novel antihypertensive peptides from wine lees hydrolysate. (1st January 2022)

• Record Type: Journal Article
• Authors: Bravo, Francisca Isabel; Mas-Capdevila, Anna; López-Fernández-Sobrino, Raúl; Torres-Fuentes, Cristina; Mulero, Miquel; Alcaide-Hidalgo, Juan María; Muguerza, Begoña
• Is Part Of: Food chemistry. Volume 366(2022)
• Publication Date: 2022-01-01
• Subjects: Hypertension -- Protein hydrolysates -- ACE inhibitory peptides -- Mass spectrometry -- Spontaneously hypertensive rats; Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; 664
• DOI: 10.1016/j.foodchem.2021.130690
• Languages: English
• ISSNs: 0308-8146

Abstract

Graphical abstract: Highlights: Novel antihypertensive peptides are generated by WL hydrolysis with Flavourzyme. TVTNPARIA, PAGELHP and LDSPSEGRAPG showed ACE inhibitory activity lower than 20 µM. Five peptides showed antihypertensive activity in SHR. Peptides could contribute to the antihypertensive effect of the WL hydrolysate. Abstract: Enzymatic-assisted extraction using Flavourzyme® has been demonstrated to be a useful methodology to obtain wine lees (WL) enriched in phenolic compounds and with enhanced antihypertensive activity. Nevertheless, taking into account that Flavourzyme® possess proteolytic activity, the release of bioactive peptides should not be ruled out. In this study, we investigate the presence of antihypertensive peptides in the WL hydrolysate. Peptides were separated into fractions by ultrafiltration and RP‐HPLC. Next, peptide identification by nano-HPLC-(Orbitrap)MS/MS was performed in the fractions showing the highest angiotensin-converting enzyme inhibitory (ACEi) activities. Six peptides were identified; three of them showing ACEi (IC50 ) values lower than 20 µM. The peptide antihypertensive effect was evaluated in spontaneously hypertensive rats at an oral dose of 10 mg/kg bw. Peptides FKTTDQQTRTTVA, NPKLVTIV, TVTNPARIA, LDSPSEGRAPG and LDSPSEGRAPGAD exhibited antihypertensive activity, confirming that they could contribute to the blood pressure-lowering effect of the WL hydrolysate. These peptides have a great potential as functional ingredients to manage hypertension.